A Study to Assess the Pharmacokinetics, Metabolism and Excretion Routes of ASP3652 in Man, After Administration of 14C Radio Labeled ASP3652
PHASE1CompletedINTERVENTIONAL
Enrollment
6
Participants
Timeline
Start Date
July 31, 2012
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
Conditions
Healthy SubjectsPharmacokinetics of ASP3652
Interventions
DRUG
ASP3652
oral
Trial Locations (1)
LS2 9LH
Covance Clinical Research Unit (CRU) Ltd., Leeds
All Listed Sponsors
lead
Astellas Pharma Europe B.V.
INDUSTRY
NCT02046798 - A Study to Assess the Pharmacokinetics, Metabolism and Excretion Routes of ASP3652 in Man, After Administration of 14C Radio Labeled ASP3652 | Biotech Hunter | Biotech Hunter